NASDAQ:NVCT | Profit Breakdown | Nuvectis Pharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$7.2M-$7.02M
2026-03-31-$6.26M-$6.05M
2025-12-31-$7.62M-$7.31M
2025-09-30-$7.79M-$7.46M
2025-06-30-$6.6M-$6.33M
2025-03-31-$5.57M-$5.33M
2024-12-31-$6.45M-$6.25M
2024-09-30-$4.36M-$4.15M
2024-06-30-$4.64M-$4.43M
2024-03-31-$4.4M-$4.17M
2023-12-31-$6.87M-$6.62M
2023-09-30-$6.16M-$5.88M
2023-06-30-$5.77M-$5.71M
2023-03-31-$4.1M-$4.05M
2022-12-31-$6.78M-$6.7M
2022-09-30-$5.94M-$5.88M
2022-06-30-$3.57M-$3.57M
2022-03-31-$2.95M-$2.94M
2021-12-31-$2.27M-$2.26M
2021-09-30-$4.67M-$4.67M
2021-06-30-$5.94M-$5.94M
2021-03-31-$23,000.00-$23,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$27.57M-$26.44M
2024-12-31-$19.85M-$19M
2023-12-31-$22.9M-$22.26M
2022-12-31-$19.23M-$19.09M
2021-12-31-$12.89M-$12.89M